The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• MicroRNA-101 (miR-101) deregulation is observed in various cancers, including lung cancer.
• The precise mechanisms and consequences of miR-101 silencing in lung cancer remain unclear.

Purpose of the Study:

• To investigate the role of miR-101 in lung cancer progression.
• To elucidate the molecular mechanisms underlying miR-101 downregulation.
• To explore the therapeutic potential of targeting the miR-101/RUNX1 axis.

Main Methods:

• Confirmation of miR-101 downregulation in lung cancer cell lines and patient tissues.
• Assessment of miR-101 restoration effects on chemotherapy sensitivity and cell invasion.
• Identification and validation of RUNX1 as a direct target of miR-101.
• Investigation of the regulatory relationship between RUNX1 and miR-101 expression via promoter analysis.

Main Results:

• miR-101 was significantly downregulated in lung cancer.
• Restored miR-101 expression enhanced chemotherapy sensitivity and inhibited invasion.
• RUNX1 was identified as a direct target of miR-101, and its expression inversely correlated with miR-101 levels.
• RUNX1 negatively regulated miR-101 transcription through direct binding to the miR-101 promoter, forming a feedback loop.

Conclusions:

• miR-101 downregulation promotes lung cancer progression in a RUNX1-dependent manner.
• The miR-101/RUNX1 feedback axis represents a potential therapeutic target for refractory lung cancer.